• Explore /
  • Poster
  • / A phase 1b trial with the combination of trabectedin and olaparib in relapsed patients (pts) with advanced and unresectable bone and soft tissue sarcomas (BSTS): An Italian sarcoma group (ISG) study.

A phase 1b trial with the combination of trabectedin and olaparib in relapsed patients (pts) with advanced and unresectable bone and soft tissue sarcomas (BSTS): An Italian sarcoma group (ISG) study.

Abstract Poster

Authors

null

Giovanni Grignani

Sarcoma Unit, Division of Medical Oncology, Candiolo Cancer Institute - FPO, IRCCS, Candiolo, Italy

Giovanni Grignani , Lorenzo D'Ambrosio , Ymera Pignochino , Emanuela Palmerini , Massimo Zucchetti , Paola Boccone , Sandra Aliberti , Raimondo Piana , Erica Palesandro , Sara Miano , Silvia Stacchiotti , Angelo Paolo Dei Tos , Emanuela Marchesi , Rossella Bertulli , Maurizio D'Incalci , Piero Picci , Stefano Ferrari , Massimo Aglietta

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2016 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Sarcoma

Track

Sarcoma

Sub Track

Soft Tissue Tumors

Clinical Trial Registration Number

NCT02398058

Citation

J Clin Oncol 34, 2016 (suppl; abstr 11018)

DOI

10.1200/JCO.2016.34.15_suppl.11018

Abstract #

11018

Poster Bd #

144

Abstract Disclosures

Similar Posters

First Author: Andres Poveda

First Author: Paul Sargos

First Author: Ecaterina Elena Dumbrava

First Author: Susanne Andrea Gatz